Select Page

Modern Genome-Based Vaccine Design

Sponsored by: EpiVax & iCubed

Venue: Pacifico Yokohama: 1-1-1, Minato Mirai, Nishi-ku, Yokohama, Japan

 Friday November 16th, 9:00 am – 5:00 pm


Speakers:

Dr. Hiroshi Kiyono M.D.

  • Professor and Dean, Institute of Medical Science,
  • University of Tokyo

Dr. Annie De Groot M.D.

  • Professor and Director, Institute of Immunology and Informatics,
  • University of Rhode Island
  • CEO/CSO, EpiVax

 Dr. Takuya Tsunoda, M.D., Ph.D.

  • President & CEO
  • OncoTherapy Science, Inc

 Dr. Eric Gowans, Ph.D.

  • NHMRC Senior Research Fellow
  • University of Adelaide

 Dr. Kenya Honda M.D.

  • Associate Professor, Department of Immunology
  • University of Tokyo

 Dr. Niranjan Sardesai, Ph.D.

  • COO
  • Inovio Pharmaceuticals

 Ms. Frances Terry

  • Bioinformatics Program Manager
  • EpiVax, Inc.

Conference Agenda

Modern Genome-Based   Vaccine Design

November 16, 2012

Time

Presenter

Topic

9:30

Dr. Hiroshi Kiyono, M.D.

Professor, University of   Tokyo

Introduction &   Welcome

9:45

Dr.   Annie DeGroot, M.D.

Professor, URI and

CEO, EpiVax

From Concept to Clinic:   Epitope-driven Vaccine Development

10:30

Break

11:00

Dr. Niranjan Sardesai

COO

Inovio Pharmaceuticals

 

DNA Vaccines: Update from   the Clinic

11:30

Dr. Eric   Gowans

NHMRC   Senior Research Fellow

University   of Adelaide

Therapeutic HCV Vaccines Based   on Dendritic Cell Delivery

12:00

Ms. Frances Terry,

Bioinformatics Program   Manager

EpiVax, Inc.

Hands-On Demonstration of iVAX Web-based Vaccine Design Toolkit

13:00

Lunch (Provided)

13:45

Dr.   Kenya Honda, M.D.

Associate Professor

University of Tokyo

Internal Influence:   Interactions Between the Human Microbiome, Autoimmunity and Allergy

14:20

Dr. Annie De Groot, M.D.

Professor, URI and

CEO, EpiVax

Driving Immunogenicity   & Tolerance: Epitope Networks

15:00

Dr. Takuya Tsunoda, M.D., Ph.D.

President & CEO

OncoTherapy Science, Inc

Development of therapeutic cancer   vaccine using dual functioning peptide cocktail targeting oncoantigen and   angiogenesis

15:50

Break

16:15

All   Speakers

Panel Discussion and   Questions from Participants

17:00

Close